Clinical trial

Olaparib for PAH: a Multicenter Clinical Trial

NCT03782818

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2019-11-20

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2019-11-20Date precision: day

Registry last updated2025-02-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Arterial Hypertensionunresolved

Interventions

OlaparibDRUG · verified · RxNorm: olaparib

Sponsors & collaborators

Laval Universitylead sponsor

Canadian Institutes of Health Research (CIHR)collaborator

AstraZenecacollaborator

Mapped research locations

TorontoOntario, Canada1 EdmontonAlberta, Canada1 QuébecQuebec, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03782818 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.